口蹄疫疫苗市场：按疫苗类型、动物类型、地区 - 规模、份额、前景、机会分析，2022-2030

口蹄疫是一种由小核糖核酸病毒科的口蹄疫病毒引起的家畜传染病。它主要影响牛、山羊、绵羊和猪等有蹄家畜。它通过直接和间接的感染途径传播。口蹄疫导致牲畜的高发病率，并由于产奶量减少、永久性蹄损伤和慢性乳腺炎而造成重大经济损失。成年牛可以从疾病中恢復，但年幼的动物没有很好的免疫力并且死亡率很高，因此接种口蹄疫疫苗至关重要。这种疾病的特点是发烧和舌头、嘴唇和嘴巴上的水疱疮。为家畜接种疫苗可以预防口蹄疫。共有七种病毒感染动物（A、O、C、SAT1、SAT2、SAT3 和 Asia1），每种毒株都会产生相似的症状，只能通过实验室检测来区分。此外，世界不同地区受到不同病毒株的影响。因此，有必要使用与每种病毒株相对应的疫苗进行预防。灭活疫苗可用于预防动物感染口蹄疫。

市场动态

预计政府组织和主要参与者之间许可协议的增加将在预测期内推动全球口蹄疫疫苗市场的增长。例如，2019 年 9 月，致力于研究牲畜传染病的研究机构 Pirbright Institute 及其研究合作伙伴宣布，提供创新兽药和疫苗服务的组织 MSD Animal Health 已获得足部试验- 和口腔疾病病毒。它已授予一种新的、有效且廉价的疫苗的独家商业许可，以保护牲畜免受多种血清型的侵害。这种疫苗从基础科学发展到动物试验，是牛津大学 Pirbright、雷丁大学 Diamond Light Source 和默克公司 (Merck & Co., Inc.) 的一个部门 MSD Animal Health 多年合作的结果。预计于 2022 年接手，将新技术推进到开发、註册和製造中。

本研究的主要特点

• 本报告对全球口蹄疫疫苗市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%) .
• 解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
• 该研究还提供了有关市场驱动因素、抑制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、关键亮点、财务业绩和战略等参数，对全球口蹄疫市场的主要参与者进行概况介绍。
• 本研究涉及的主要公司包括 Agrovet Indian Immunologicals Ltd.、MSD Animal Health、Vallee SA、Bayer HealthCare、Brilliant Bio Pharma Ltd.、Intervet、Biovet、Merial、China Animal Husbandry Co., Ltd.、Biogenesis -Bago S.A、Vetal Animal Health Products S.A.VETAL Animal Health Products 和 Vecol S.A.
• 本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 《全球口蹄疫疫苗市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
• 通过用于分析全球口蹄疫疫苗市场的各种策略矩阵，可以轻鬆做出决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第2章市场展望

• 举报内容
  • 市场定义和范围
• 执行摘要
  • 市场快照：按疫苗类型
  • 市场快照：按动物类型
  • 市场概况：按地区划分
  • 举报内容
  • 执行摘要
• 连贯的机会图 (COM)

第 3 章市场动态、法规和趋势分析

• 市场动态
  • 驱动程序
  • 约束因素
  • 市场机会
• 影响分析
• 新品发布
• 併购
• 监管场景
• 行业专家的推荐
• PEST 分析
• 波特五力模型
• 政府举措
• 流行病学

第 4 章全球口蹄疫疫苗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府举措
• COVID-19 对市场的影响

第 5 章全球口蹄疫疫苗市场，按疫苗类型，2017-2030 年

• 常规疫苗
• 氢氧化铝疫苗
• 油基疫苗
• 紧急疫苗

第 6 章按动物分列的 FMD 疫苗全球市场，2017-2030 年

• 牛
• 绵羊和山羊
• 猪
• 其他

第 7 章按地区分列的全球口蹄疫疫苗市场，2017-2030 年

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海合会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第 8 章竞争格局

• Agrovet
• India Immunologicals Ltd.
• Merck Animal Health
• Shanghai Hile Bio-Pharmaceutical Co., Ltd.
• Vallee SA
• Brilliant Bio Pharma Ltd
• Merial
• China Animal Husbandry Co., Ltd.
• Biogenesis-Bago S.A.
• Vetal Animal Health Products S.A.
• Vecol S

第9章 章节

• 参考文献
• 调查手法

Foot and Mouth Disease (FMD) is infectious disease in domestic animals caused due to viral strain Aphtovirus of the family picornaviridae. It majorly affects cloven hooved livestock such as cattle, goat, sheep, swine, and other animals. It can spread through both direct and indirect modes. Foot and mouth disease causes high morbidity in animals and results into significant economic loss due to decreased milk production, permanent hoof damage, and chronic mastitis. Although adult animals can recover from the disease, mortality is high among young animals, as immunity is not well developed due to which foot and mouth disease vaccination is essential. The disease is characterized by fever and blistery sore on tongue, lips and oral cavity. Foot and mouth disease is best preventable by vaccinating the livestock. There are total seven strains (A, O, C, SAT1, SAT2, SAT3, and Asia1) of the virus that affect animals, symptoms produced are similar in each strain and they can be distinguished only through laboratory tests. Various regions around the world are affected by different set of viral strains. Therefore each strain requires specific vaccine to prevent the infection. Inactivated vaccines are available to prevent animals from being infected by foot and mouth disease.

Market Dynamics

Increasing licensing agreements between government organization and key players are expected to drive market growth of the global foot and mouth disease vaccine market over the forecast period. For instance, in September 2019, Pirbright Institute, a research institute dedicated to the study of infectious diseases of farm animals, and its research partners had granted MSD Animal Health, the organizational company that offers innovative veterinary pharmaceuticals and vaccines services, an exclusive commercial licence for a new, effective, and affordable vaccine to protect livestock against several serotypes of foot-and-mouth disease virus. The vaccine has been developed from basic science to animal trials as a result of long-standing collaborations between Pirbright, the University of Oxford, Diamond Light Source, the University of Reading, and MSD Animal Health, a division of Merck & Co., Inc., who will be taken in 2022 forward the new technology into development, registration and manufacturing.

Key features of the study:

• This report provides an in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Agrovet Indian Immunologicals Ltd., MSD Animal Health, Vallee SA, Bayer HealthCare, Brilliant Bio Pharma Ltd., Intervet, Biovet, Merial, China Animal Husbandry Co., Ltd., Biogenesis-Bago S.A, Vetal Animal Health Products S.A.VETAL Animal Health Products, and Vecol S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation:

• Global Foot and Mouth Disease Vaccine Market, By Vaccine Type:
  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines
• Global Foot and Mouth Disease Vaccine Market, By Animal Type:
  • Cattle
  • Sheep and Goat
  • Swine
  • Others
• Global Foot and Mouth Disease Vaccine Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Agrovet*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • India Immunologicals Ltd.
  • Merck Animal Health
  • Shanghai Hile Bio-Pharmaceutical Co., Ltd.
  • Vallee SA
  • Brilliant Bio Pharma Ltd
  • Merial
  • China Animal Husbandry Co., Ltd.
  • Biogenesis-Bago S.A.
  • Vetal Animal Health Products S.A.
  • Vecol S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
  • Report Description
  • Executive Summary
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• New Product Launches
• Mergers and Acquisitions
• Regulatory Scenario
• Testimonials from Industry Expert
• PEST Analysis
• Porters Five Forces model
• Government Initiative
• Epidemiology

4. Global Foot and Mouth Disease Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Foot and Mouth Disease Vaccine Market , By Vaccine Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Conventional Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Aluminum Hydroxide based vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Oil based vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Emergency Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Foot and Mouth Disease Vaccine Market , By Animal Type , 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cattle
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Sheep and Goat
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Swine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Foot and Mouth Disease Vaccine Market , By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• UK
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Agrovet*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• India Immunologicals Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Shanghai Hile Bio-Pharmaceutical Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vallee SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Brilliant Bio Pharma Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merial
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• China Animal Husbandry Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biogenesis-Bago S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vetal Animal Health Products S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vecol S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• References
• Research Methodology
• About Us and Sales Contact